SCHEMBL30845571

SCHEMBL30845571

COC(=O)c1ccc(C2CC2)c(F)c1S(=O)(=O)Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.38
PDK4 Q16654 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
NOTUM Q6P988 1/20 0.35
SLC6A3 Q01959 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
SLC6A4 P31645 1/20 0.34
HCRTR2 O43614 2/20 0.34
KDM4E B2RXH2 2/20 0.34
POLB P06746 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30845562 0.89 PDK2 (0.38) PDK2PDK4ALDH1A1HSD17B10HPGD
SCHEMBL8579296 0.80 PDK2 (0.39) PDK2PDK4ALDH1A1HSD17B10HPGD
SCHEMBL31413076 0.77 PDK2 (0.48) PDK2PDK4ALDH1A1HSD17B10HPGD
SCHEMBL8583685 0.75 ALDH1A1 (0.42) PDK2PDK4ALDH1A1HSD17B10HPGD
SCHEMBL8581200 0.75 ALOX5AP (0.37) PDK2PDK4ALDH1A1HSD17B10HPGD
SCHEMBL24928885 0.74 PTGER4 (0.43) PDK2PDK4ALDH1A1HSD17B10HPGD
SCHEMBL10986337 0.74 CA1 (0.51) ALDH1A1HSD17B10TSHRSLC6A3SLC6A4
SCHEMBL7034611 0.74 CA1 (0.45) ALDH1A1HSD17B10HPGDTSHRSLC6A3
SCHEMBL8580134 0.74 YAP1 (0.39) ALDH1A1HSD17B10HPGDTSHRSMN1; SMN2
SCHEMBL24928665 0.73 ALDH1A1 (0.42) ALDH1A1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881657-A Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1 modulators 格雷沃尔夫治疗有限公司 2024-04-12 CN disclosed